40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
11.20%
Revenue growth below 50% of CRK's 23.10%. Michael Burry would check for competitive disadvantage risks.
-5.52%
Cost reduction while CRK shows 16.94% growth. Joel Greenblatt would examine competitive advantage.
38.86%
Gross profit growth exceeding 1.5x CRK's 24.62%. David Dodd would verify competitive advantages.
24.88%
Margin expansion exceeding 1.5x CRK's 1.23%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.19%
Other expenses growth less than half of CRK's 9.38%. David Dodd would verify if advantage is sustainable.
2.94%
Operating expenses growth while CRK reduces costs. John Neff would investigate differences.
-3.32%
Total costs reduction while CRK shows 4.87% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-4.52%
D&A reduction while CRK shows 9.00% growth. Joel Greenblatt would examine efficiency.
38.11%
EBITDA growth 1.25-1.5x CRK's 32.11%. Bruce Berkowitz would examine sustainability.
96.98%
EBITDA margin growth exceeding 1.5x CRK's 7.45%. David Dodd would verify competitive advantages.
90.15%
Operating income growth exceeding 1.5x CRK's 51.73%. David Dodd would verify competitive advantages.
71.00%
Operating margin growth exceeding 1.5x CRK's 23.26%. David Dodd would verify competitive advantages.
-1749.84%
Other expenses reduction while CRK shows 542.08% growth. Joel Greenblatt would examine advantage.
-61.27%
Pre-tax income decline while CRK shows 60.39% growth. Joel Greenblatt would examine position.
-65.17%
Pre-tax margin decline while CRK shows 30.30% growth. Joel Greenblatt would examine position.
1085.14%
Tax expense growth above 1.5x CRK's 50.82%. Michael Burry would check for concerning trends.
-91.39%
Net income decline while CRK shows 89.40% growth. Joel Greenblatt would examine position.
-92.26%
Net margin decline while CRK shows 53.85% growth. Joel Greenblatt would examine position.
-91.71%
EPS decline while CRK shows 84.96% growth. Joel Greenblatt would examine position.
-91.71%
Diluted EPS decline while CRK shows 82.93% growth. Joel Greenblatt would examine position.
3.13%
Share count reduction below 50% of CRK's 1.46%. Michael Burry would check for concerns.
3.61%
Diluted share reduction below 50% of CRK's 0.88%. Michael Burry would check for concerns.